Newmont Corporation vs Twist Bioscience Corp — how do they compare? Newmont Corporation trades at $118.98 (market cap $123.50B), while Twist Bioscience Corp trades at $123 (market cap $7.72B). The key difference: Newmont Corporation is far larger — about 16× Twist Bioscience Corp's market cap, and Newmont Corporation pays a 0.89% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NEM | TWST | |
|---|---|---|
Market Cap | $123.50B | $7.72B |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $124.88 |
52-Week Low | $67.38 | $24.16 |
Enterprise Value | $120.09B | $7.65B |
Dividend Yield | 0.89% | — |
Trailing returns across standard periods
Latest headlines on both assets
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →